Furthermore, dynamic changes of PD-L1 expression in tumor cells might occur before or under therapy with PD-1/PD-L1 inhibitors, leading to different sensitivity to PD-1/PD-L1 blockade which would similarly be missed by one single biopsy. The gene discussed is CD274; the disease is neoplasm.